CBDV
CBDV, cannabidivarin
pronounced: kan-uh-bih-dih-VAIR-in
CBD’s slimmer cousin - non-intoxicating and studied for seizures.
Cannabidivarin · 286.4 g/mol
The molecule
Chemical structure
This is the accurate skeletal structure of CBDV, drawn from PubChem data. Each corner and line-end is a carbon atom, and the red O marks oxygen. Its formula is C19H26O2 and it weighs 286.4 g/mol.
About
What is CBDV?
Cannabidivarin, or CBDV, is the slimmer cousin of CBD, with a shorter carbon tail. Like CBD, it does not make you high.
It is usually a minor part of the plant, though some varieties, especially certain landrace plants from Asia, contain more of it.
In the body
How CBDV Works
CBDV has very little direct action at the CB1 and CB2 receptors. Instead it works mainly through the body's TRP channels, which are involved in pain, inflammation and the control of nerve excitability.
Its most studied use is as an anticonvulsant. Animal research has shown it can reduce seizures, and it has also been explored for behaviours linked with autism. Human research is still at an early stage.
Receptor snapshot
Where CBDV Acts
The endocannabinoid system has two main receptors. Here is how strongly CBDV acts on each.
Very little direct action at CB1, so no high.
Weak action at CB2.
In the plant
How CBDV is Made
CBDV is made from its acid, CBDVA, on the same "propyl" branch of the family tree as THCV, starting from the shorter-tailed mother acid CBGVA.
Heat turns CBDVA into CBDV.
Good to know
Safety and Side Effects
CBDV has been well tolerated in the clinical trials done so far, with mild side effects such as stomach upset. As an experimental compound, its long-term safety is still being studied.
It is not a licensed medicine on its own, so only use it under the guidance of a prescriber.
Questions
CBDV: Common Questions
What is CBDV used for?
Does CBDV get you high?
References
- Hill, A.J. et al. (2012) 'Cannabidivarin is anticonvulsant in mouse and rat', British Journal of Pharmacology, 167(8), pp. 1629-1642. doi: 10.1111/j.1476-5381.2012.02207.x.
- Izzo, A.A., Borrelli, F., Capasso, R., Di Marzo, V. and Mechoulam, R. (2009) 'Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb', Trends in Pharmacological Sciences, 30(10), pp. 515-527. doi: 10.1016/j.tips.2009.07.006.
- National Center for Biotechnology Information (2025) PubChem Compound Database. Bethesda: U.S. National Library of Medicine. Available at: https://pubchem.ncbi.nlm.nih.gov (Accessed: 29 July 2026).
- Morales, P., Hurst, D.P. and Reggio, P.H. (2017) 'Molecular targets of the phytocannabinoids: a complex picture', Progress in the Chemistry of Organic Natural Products, 103, pp. 103-131. doi: 10.1007/978-3-319-45541-9_4.